The Asian Scientist 100
Di Li
Institution
National Astronomical Observatories of the Chinese Academy of Sciences
Country
China
Field
Aerospace & Astronomy
Li received the Marcel Grossmann Award for his pioneering contributions in the field of fast radio bursts. Li is the first scientist in China to receive this prize for research conducted within China.
(Photo: The Paper)
AWARDS
- Marcel Grossmann Award
Related articles
Soldier Beetles Synthesize Fatty Acids For Defense
Scientists have discovered the three genes that combine to provide soldier beetles with their potent predator defense system.
Quality Education Still A Long Way Off In Pakistan
Despite making education a constitutional right in 2010, Pakistan is unlikely to fulfill its Millennium Development Goal of achieving universal education by 2015.
1000 Genomes Project Helps Advance Personalized Medicine
By decoding the genomes of more than 1,000 people from Han Chinese in Beijing to Japanese in Tokyo, scientists have compiled the largest and most detailed catalog yet of human genetic variation.
Huge Jurassic Fossil Turtle Graveyard Found in China
Paleontologists from Germany have made a spectacular find of 1,800 fossilized turtles from the Jurassic era in China’s northwest province of Xinjiang.
Mainstreaming Science In South Asia
Educating children and women is essential to mainstreaming science in South Asia, writes T. V. Padma.
Koshik The ‘Korean’ Elephant Can Say Annyong, Anja, Aniya, Nuo, And Choah
An Asian elephant named Koshik can imitate human speech, speaking a grand total of five words in Korean by vocalizing with his trunk in his mouth.
Indonesia’s Plans To Cut Science Classes Raise Protests
Despite protests by parents, educators, and education observers, the Indonesian government is still moving forward to eliminate science classes from elementary schools.
TauRx Therapeutics Initiates Two Phase III Trials For Alzheimer’s Drug
Singapore-based biotech company TauRx Therapeutics Ltd announced today the initiation of two global Phase III clinical trials for its Alzheimer’s disease drug.
Novartis To Build US$500m Biotech Facility In Singapore
Novartis announced today the construction of a new state-of-the-art biotechnology facility in Singapore with an investment valued at over US$500 million.